Apyx Medical (APYX) Fundamental Analysis: Revenue, Earnings & Valuation

9.78 / 10

Outperform

Fundamentally APYX outperforms with a 9.8/10 health score. Profit‑MV (+0.66) and revenue‑MV (+0.66) rank in top groups, supporting strong earnings and cash‑flow ratios. Cash‑MV and ROA are weak, dragging cash‑MV and return metrics, but overall fundamentals remain robust.

Analysis Checks(4/10)

Revenue-MV

Value-0.29

Score3/3

Weight185.69%

1M Return2.75%

ROA (%)

Value-16.87

Score1/3

Weight-47.78%

1M Return-0.82%

Net cash flow from operating activities / Operating revenue (%)

Value-15.14

Score2/3

Weight100.30%

1M Return1.48%

Profit-MV

Value0.66

Score2/3

Weight216.52%

1M Return3.09%

Annualized net profit margin on total assets (%)

Value-16.87

Score1/3

Weight-47.78%

1M Return-0.82%

EBIT / Total operating revenue (%)

Value-12.02

Score1/3

Weight-42.60%

1M Return-0.83%

Asset-MV

Value-0.55

Score1/3

Weight23.12%

1M Return0.38%

Net profit / Total operating revenue (%)

Value-21.01

Score1/3

Weight-48.66%

1M Return-0.84%

Cash-MV

Value0.02

Score1/3

Weight-205.25%

1M Return-4.16%

Net profit / Total profit (%)

Value102.49

Score2/3

Weight-33.55%

1M Return-0.54%

Is APYX fundamentally strong?

APYX scores 9.78/10 on fundamentals and holds a Discounted valuation at present. Backed by its -76.88% ROE, -21.01% net margin, -13.77 P/E ratio, 10.41 P/B ratio, and 59.09% earnings growth, these metrics solidify its Outperform investment rating.